10021

Fine Needle Aspiration Biopsy without Imaging Guidance, Initial Lesion

CPT code 10021 represents a fine needle aspiration (FNA) biopsy performed without the aid of imaging guidance on an initial lesion. This diagnostic procedure involves the use of a fine-gauge needle, typically ranging from 22 to 27 gauge, which is inserted into a palpable mass to obtain cellular material for cytopathological examination. Unlike a core needle biopsy, which retrieves a solid cylinder of tissue to preserve histological architecture, FNA focuses on extracting individual cells, small clusters, or fluid for cytology. This technique is highly effective for investigating suspicious nodules in the thyroid, breast, lymph nodes, salivary glands, and other superficial soft tissues. The clinician identifies the target through physical palpation rather than ultrasound, CT, or fluoroscopy. Once the needle is positioned within the mass, the practitioner may apply suction using a syringe (aspiration technique) or rely on capillary action by moving the needle back and forth in a fanning motion (non-aspiration technique). This action dislodges cells into the needle's lumen. The collected material is then expelled onto glass slides for fixed smears or placed into a liquid preservative medium for thin-layer processing. This procedure is valued for its minimally invasive nature, low complication rate, and rapid turnaround for results. It provides critical information regarding the benign or malignant nature of a lesion, often determining the next steps in clinical management, such as surgical excision, further imaging, or continued observation. The coding of this procedure is strictly limited to the first lesion sampled using this specific non-guided technique during a single encounter.

Clinical Indications

  • Evaluation of a palpable thyroid nodule to rule out malignancy.
  • Investigation of suspicious superficial lymphadenopathy (e.g., enlarged cervical or axillary lymph nodes).
  • Diagnostic sampling of a palpable breast mass.
  • Assessment of salivary gland tumors (e.g., parotid or submandibular gland masses).
  • Sampling of superficial soft tissue masses or subcutaneous nodules of uncertain etiology.
  • Drainage and cytologic evaluation of symptomatic or suspicious cysts.

Procedure Steps

  1. Verify patient identity and obtain informed consent for the biopsy.
  2. Perform physical palpation to identify and stabilize the target lesion.
  3. Clean the skin overlying the lesion with an antiseptic solution (e.g., alcohol or povidone-iodine).
  4. Optionally administer a local anesthetic (though often omitted for FNA due to the needle size being similar to the anesthetic needle).
  5. Insert a fine-gauge needle (22-27 G) through the skin and into the palpated mass.
  6. Perform the aspiration or non-aspiration technique, moving the needle through the lesion in several directions (fanning).
  7. Withdraw the needle once sufficient cellular material is visible in the hub or needle shaft.
  8. Apply pressure to the puncture site to achieve hemostasis.
  9. Expel the collected material onto glass slides for immediate fixation or into a transport medium for liquid-based cytology.
  10. Ensure all specimens are labeled correctly and documented in the patient record.

Coding Guidelines

  • Use 10021 for the first lesion biopsied without imaging guidance during a session.
  • For each additional lesion biopsied without imaging guidance, use the add-on code +10004.
  • If imaging guidance (ultrasound, fluoroscopy, CT, or MRI) is used, do not report 10021; instead, refer to codes 10005-10012 based on the modality used.
  • If both a fine needle aspiration and a core needle biopsy (e.g., 19081, 60100) are performed on the same lesion, both may be reported, but 10021 would represent the FNA component.
  • Do not report 10021 in conjunction with 88172 or 88173 (cytopathology evaluation) unless the physician performing the FNA also performs the pathological interpretation.
  • The procedure includes local anesthesia and any immediate post-procedure care.